Related Experiment Videos
Venture capital for the pharmacologist
1Mediphase Venture Partners, Newton, MA, USA. lmiller@mediphaseventure.com
Molecular Interventions
|March 3, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Risk factors for transmission of carbapenem-resistant Enterobacterales to healthcare personnel gloves and gowns in the USA.
The Journal of hospital infection·2020
Discontinuation of contact precautions with the introduction of universal daily chlorhexidine bathing.
Epidemiology and infection·2017
Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Spindle poisons and cell fate: a tale of two pathways.
Molecular interventions·2011
CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.
Molecular interventions·2011
Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states.
Molecular interventions·2011
Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?
Molecular interventions·2011
NOX isoforms and reactive oxygen species in vascular health.
Molecular interventions·2011
Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.
Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026
Unveiling the sumatriptan dose-relief relationship.
European journal of clinical pharmacology·2026
Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).
Therapeutic drug monitoring·2026
Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.
International journal of pharmaceutics·2026